Safety of COVID-19 Vaccination in Patients With Breast Cancer: Cross-Sectional Study in China (Preprint)
Shaohua Zhang(Wenzhou Medical University), Zefei Jiang, Ruonan Xu(Medical University of Graz), Xinlan Liu(Yunnan Agricultural University), Zhimin Fan(Nanjing University of Chinese Medicine), Yuee Teng(First Hospital of China Medical University), Jianbin Li(Academy of Military Medical Sciences), Hong Liu(Tianjin Medical University Cancer Institute and Hospital), Yali Cao(Third Hospital of Nanchang), Cuizhi Geng(Hebei Medical University), Feng Jin(Hebei University), Fu‐Sheng Wang(National Clinical Research Center for Digestive Diseases), Yiding Chen(Second Affiliated Hospital of Zhejiang University), Xinzheng Li(Shanxi Provincial Cancer Hospital), Jianyun Nie(Kunming Medical University), Gang Sun(Xinjiang Medical University), Guiying Xu(Soochow University), Ting Luo(Inserm), Qianjun Chen(Guangzhou University of Chinese Medicine), Ying Lin(Sun Yat-sen University)
Cited by 0
Related Papers
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
|New England Journal of Medicine|2022|2.5k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
|Annals of Oncology|2017|1.3k